Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150
CANO.WS
CANO.WS was delisted on the 9th of November, 2023.
Fund managers haven’t disclosed any holdings of CANO.WS yet.
CANO.WS Hedge Fund Activity: Q1 2024 in Review
0 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 (CANO.WS) for Q1 2024, worth a combined $0 — down 100% from $279 a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of CANO.WS and 0 opened new positions — a net loss of 2 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Josh Arnold Investment Consultant, exiting entirely with an estimated $254 sold.
- 0 institutional investors held Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 (CANO.WS) as of Q1 2024, down from 2 in Q4 2023.
- Funds reported $0 of Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 stock for Q1 2024, down 100% quarter-over-quarter.
- 0 funds opened new Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 positions in Q1 2024 and 2 closed out, a net change of -2 holders.
- The largest Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 seller in Q1 2024 was Josh Arnold Investment Consultant, an estimated $254 sold.
Based on aggregated 13F filings for Q1 2024.